NPPB and hydrops fetalis: Natriuretic peptides (NP), the brain natriuretic peptide (BNP) and N-Terminal-pro-BNP (NT-pro-BNP; a fragment of the BNP precursor) represent the most extensively employed biomarkers in HF patients; their role has been stablished in diagnosis and risk stratification in these patients [88,89].